Can the covid vaccine be given with Fasenra, Dupixent or Nucala?
Within the first year of the COVID 19 pandemic, two vaccines were approved for FDA emergency use by Pfizer and Moderna. Patients who have severe asthma may be on biologic immunomodulators which may affect the immune response to these vaccines. The cytokines that are affected by them are IL-4, IL-5 and IL-13 which also may play a role in normal immunity. Most biologic treatments are not generally associated with major risks of viral or bacterial infections, but a recent study published in The Journal of Allergy and Clinical Immunology, Volume 154. No. 2, August 2024 titled “Patients taking benralizumab, dupilumab or mepolizumab have lower postvaccination SARS-CoV-2 immunity” examined this.
Patients who have severe asthma or eczema who were taking Fasenra, Dupixent or Nucala received either mRNA vaccine and were compared to a control group of healthy subjects who were not taking any biologics. Patients who are on these biologic medications typically have severe symptoms and and exacerbations which led them to starting these medications and they have led to improved quality of life.
The patients who were on one of the biologics had reduced SARS-CoV-2 specific antibody titers, neutralizing activity and virus specific B and CD8 T Cell counts. These results have implications for those who are on the medications who will receive the COVID vaccines.
The inhibition of the IL-4 or IL-5 pathways is associated with less immunity. Because each biologic has a different mechanism of action targeting different molecules and receptors, the mechanism of impairment of postvaccination immunity for each biologic will likely be different.
This could place those subjects who are on benralizumab, dupilumab, or mepolizumab at increased risk of COVID-19 infection despite vaccination.
Update October 8, 2024
A recent study looked at patients on Dupixent receiving live vaccines. The package insert recommend that patients who are being treated with Dupixent should avoid live vaccines. The available literature on patients who received vaccinations while using Dupixent overall suggests that live vaccines are safe and the vaccine efficacy, in general, is not affected by dupilumab. It is suggested, receiving Dupixent and the use of vaccines (including live ones) is likely safe and effective. This is a decision that a patient and doctor should decide together.
Can the Covid Vaccine cause Hives?
Allergic Reactions to Covid Vaccines an update
Moderna Covid Vaccine and Allergy
New Asthma Drug Nucala (Mepolizumab) for Severe Eosinophilic Asthma
Dupilumab (Dupixent) for Atopic Dermatitis (Eczema) Sufferers
